William Lumry, MD

William Lumry, MD: Founder of the Allergy & Asthma Specialists of Dallas

Articles by William Lumry, MD

Switching to Donidalorsen for HAE, With William Lumry, MD

October 8th 2025

Donidalorsen demonstrates strong efficacy in patients switching from other HAE prophylactic treatments. Lumry discusses pivotal data after FDA approval.

FDA’s Approval of Donidalorsen for HAE, With William Lumry, MD

ByWilliam Lumry, MD

October 7th 2025

Lumry discuses donidalorsen, the first FDA-approved, RNA-targeted therapy for hereditary angioedema.

William Lumry, MD

Articles by William Lumry, MD

Switching to Donidalorsen for HAE, With William Lumry, MD

FDA’s Approval of Donidalorsen for HAE, With William Lumry, MD

Latest Updated Articles

Trending on HCPLive

SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study

Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial

Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs

What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD